Rindex obtains license for AF prediction technology

05/1/2013 | MedCityNews.com

Rindex Medical has gained exclusive license from the Cleveland Clinic to develop the A-50 AF Prediction System, a tool that doctors can use to predict a patient's risk for atrial fibrillation after cardiac surgery. The Redwood City, Calif.-based startup has a working prototype of the device and is preparing to apply for 510(k) clearance.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC